Otis shareholder plans Rule 144 sale of 47,944 shares

A shareholder of Otis Worldwide (OTIS) has filed a Rule 144 notice to sell 47,944 shares of common stock through UBS Financial Services Inc. on the NYSE, with an aggregate market value of $4,423,313.

Accepted by SEC EDGAR 02/12/2026 - 03:24 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder of Otis Worldwide (OTIS) has filed a Rule 144 notice to sell 47,944 shares of common stock through UBS Financial Services Inc. on the NYSE, with an aggregate market value of $4,423,313. The filing lists 388,720,773 common shares outstanding at the time of the notice.

The shares proposed for sale were acquired through restricted stock unit (RSU) vestings on multiple dates, including 20,842 shares on February 6, 2024, 20,599 shares on June 1, 2023, and 6,503 shares on February 4, 2023, all settled by wire payment. The approximate sale date indicated is February 12, 2026, and the signer represents they are not aware of undisclosed material adverse information about Otis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Otis (OTIS) disclose?

The Form 144 discloses a planned sale of 47,944 Otis common shares on the NYSE through UBS Financial Services Inc., with an indicated aggregate market value of $4,423,313, under Rule 144 resale provisions for restricted or control securities.

How many Otis (OTIS) shares are planned to be sold and on which exchange?

The filing shows a planned sale of 47,944 Otis common shares on the NYSE. The shares are to be sold through UBS Financial Services Inc. as broker, under Rule 144, which governs resales of restricted or control securities.

What aggregate market value is associated with the Otis (OTIS) shares in this Form 144?

The planned sale of 47,944 Otis common shares is associated with an aggregate market value of $4,423,313. This figure reflects the market value of the shares covered by the notice at the time the Form 144 was prepared.

How many Otis (OTIS) shares were outstanding according to this Form 144?

The Form 144 states that 388,720,773 Otis common shares were outstanding. This number provides context for the relative size of the 47,944-share planned sale disclosed in the notice under Rule 144.

How were the Otis (OTIS) shares in the Form 144 acquired?

The shares were acquired via RSU vesting transactions. The filing lists acquisitions of 20,842 shares on February 6, 2024, 20,599 shares on June 1, 2023, and 6,503 shares on February 4, 2023, all settled by wire payment.

What is the approximate sale date for the Otis (OTIS) shares in this Form 144?

The notice indicates an approximate sale date of February 12, 2026 for the 47,944 Otis common shares. This is the date by which the shareholder expects to begin selling the shares subject to Rule 144 conditions.

What representation does the selling holder make in the Otis (OTIS) Form 144?

By signing the notice, the selling holder represents that they do not know any material adverse information about Otis’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 and related securities law requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001807059
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Otis Worldwide
SEC File Number	001-39221
Address of Issuer	One Carrier Place Farmington CONNECTICUT 06032
Phone	8606743000
Name of Person for Whose Account the Securities are To Be Sold	Stephane de Montlivault
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	47944	4423313	388720773	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/06/2024	RSU Vesting	Otis			20842	02/06/2024	Wire
Common	06/01/2023	RSU Vesting	Otis			20599	06/01/2023	Wire
Common	02/04/2023	RSU Vesting	Otis			6503	02/04/2023	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Stephane de Montlivault
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)